Combined use of painkillers, antidepressants may increase bleeding risk
the ONA take:
According to a study published this week in The BMJ, researchers have found that combined use of antidepressants and NSAID painkillers is associated with an increased risk of bleeding.
For the study, researchers analyzed data from more than 4 million people who were prescribed antidepressants between 2009 and 2013 included in the Korean nationwide health insurance database. Researchers compared the time to first admission with intracranial hemorrhage within 30 days of a new prescription among patients with antidepressants and NSAIDs compared with those with only antidepressants.
Results showed a substantially increased bleeding risk among those who took both prescription medications. Moreover, there was no statistically significant difference in risk of bleeding with age or different classes of antidepressant medications. Male gender was also found to be associated with a higher risk of bleeding among those who were prescribed the combination.
The authors note that their results may have been impacted by other factors and caution is advised when interpreting the results; however, health care professionals should use caution in patients who are prescribed both types of medications.
Researchers have found that combined use of antidepressants and NSAID painkillers is associated with an increased risk of bleeding.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|